Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vladimir Masin is active.

Publication


Featured researches published by Vladimir Masin.


Pteridines | 2005

Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis

Melanie Cermanová; Bohuslav Melichar; Dagmar Solichová; M. Blaha; V. Blaha; M. Blazek; Vladimir Masin; Jaroslav Cerman; Zdenek Zadak

Abstract Low-density lipoprotein (LDL)-apheresis is a method of extracorporeal elimination of LDL-cholesterol in patients with severe primary lipoprotein disorders. LDL-cholesterol activates macrophages, which play an important role in atheromatous plaque formation. In the present study, we have investigated urinary neopterin, a specific marker of macrophage activation and microalbuminuria, an indicator of generalized vascular dysfunction, after a single LDL-apheresis procedure in 10 patients with severe primary lipoprotein disorder. The urinary neopterin/creatinine ratio was increased in patients compared to controls. No significant changes of the neopterin/creatinine and albumin/creatinine ratios were observed after LDL-apheresis, except a significant (p < 0.006) decrease of urinary neopterin/creatinine ratio in the evening after the apheresis. This decrease showed significant negative correlation with the pre-apheretic levels of atherogenic cholesterol fractions (p < 0.05) and with cholesterol decrease during the apheresis (p < 0.05). Urinary albumin/creatinine ratio correlated positively with total and LDL-cholesterol levels before the apheresis and with the evening urinary neopterin/creatinine ratio after the apheresis, but did not correlate with glycemia and triacylglycerides. Elevated urinary neopterin in the patients with severe primary lipoprotein disorders reflects the presence of atherosclerosis. A single LDL-apheresis procedure did not significantly affect microalbuminuria. The decrease of urinary neopterin in the evening after the apheresis corresponds with the diurnal rhythm of neopterin excretion and was less pronounced in patients with more severe hypercholesterolemia. The correlations between microalbuminuria, neopterin and pre-apheretic cholesterol concentrations indicate a possible connection between microvascular dysfunction, macrophage activity and severity of hyperlipidemia, but these results should be interpreted with caution because of small number of subjects evaluated.


Transfusion and Apheresis Science | 2009

WAA apheresis registry in the Czech Republic: two centers experience.

M. Blaha; Jan Pták; Jan Čáp; Věra Ceeová; Vladimir Masin; Stanislav Filip; Martin Blažek

INTRODUCTION Hemaphereses are sophisticated procedures performed for many indications even in severely ill patients. Many authors consider quite necessary to register as many details as possible of treatments with therapeutic apheresis. WAA meets the requirement to compare data with centers not performing apheresis for the same diagnosis. In Czech Republic hemaphereses are used in a broad spectrum of indications. Since the year 2004 data on hemaphereses done in Czech Republic have been registered. In this paper we present a survey of our to date recordings. PATIENTS AND METHODS Data of performed therapeutic hemaphereses (plasma exchange, erythrocytapheresis, leukapheresis, thrombocytapheresis, photopheresis, immunopheresis, and rheopheresis) have been entered in WAA registry with many details. We have been evaluated 1289 procedures in 216 patients done in our two centers (center I, center II). RESULTS Center I registered 129 procedures in 41 patients, center II 1260 procedures in 175 patients. The patients are divided according to centers specialization (center II has registered 12 long-term treated patients with LDL-apheresis; mean time of therapy 7.1 years and a median of 34 procedures/patient. Side-effects registered in center I and center II were 3.1% and 5.6% of the procedures, respectively. Most frequent side-effects were citrate toxicity, neurovegetative lability, problems with venous access and hypotension. All were easy to treat, no serious events or death occurred. CONCLUSIONS In Czech Republic hemaphereses are performed in a broad scale of indications and now it is nearly 5 years that data are registered in our two university centers. In 2004 we entered WAA registry because it meets the requirement to compare data with centers that do not perform aphereses for the same diagnosis. This comparison would certainly improve efficacy of the hemapheresis therapy even further. To enter WAA registry is easy, at no expense and without any problems.


Acta Odontologica Scandinavica | 2010

Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus.

Vladimíra Paulusová; Christiane Rösch; Ivo Dřízhal; František Perlík; Vladimir Masin; Sujith Sukumar; Radovan Slezák; Ondřej Slanař

Abstract Objective. Oral lichen planus (OLP) is one of the commonest diseases of the oral mucosa. The etiology of the disease is unknown. Our goal was to determine frequencies of functionally important alleles which determine the metabolic rate (phenotype) of individuals with OLP and to compare drug utilization, with focus on CYP2D6, with that of a control group. Material and methods. The study population consisted of 46 patients with OLP, 60 sex- and age-matched control subjects for drug utilization evaluation and 223 healthy non-medicated controls for genotype comparison. DNA analysis was done using polymerase chain reaction and restriction fragment length polymorphism. The gene CYP2D6 was analyzed for the alleles CYP2D6*3,*4,*5,*6 and gene duplication. Drug utilization was evaluated according to Anatomical Therapeutic Chemical code, liver drug metabolism pathway and mono- or polytherapy. Results. Intake of drugs was significantly higher in the group of OLP patients in comparison with control subjects. The use of CYP2D6 substrates, inhibitors or inducers did not differ between OLP patients and controls. Predicted phenotype frequencies in OLP patients and healthy controls, respectively were as follows: ultrarapid metabolizers 2% and 5.8%, extensive metabolizers 52% and 49.8%, intermediate metabolizers 39% and 37.7% and poor metabolizers 7% and 6.7%. Conclusions. We did not find a statistically significant difference in the frequency of CYP2D6 alleles between OLP patients and healthy controls. OLP patients used more medication than age- and sex-matched controls.


Analytica Chimica Acta | 1978

The use of cerium(IV) phosphate for the gravimetric determination and separation of cerium

Vladimir Masin; J. Doležal

A method for the gravimetric determination of cerium as Ce3(PO4)4 is described. Cerium can be separated from many metals in this form, as well as from permanganate and dichromate; the cerium separated can then be titrated with iron(II) solution. The method was verified for the determination of cerium in a rare earth concentrate.


federated conference on computer science and information systems | 2017

Moodle portal in virtualized environment — A performance analysis

Vladimir Masin; Martin Kopecek; Josef Hanus

The Moodle portal of our faculty is running in a virtualized environment together with other about 50 application servers and 60 virtualized desktops. Increasing traffic on the site (reaching over 400 000 views/posts monthly) forced us to assess its performance impact on the virtualization environment. The performance analysis identified processor cycles and disk operations as the bottlenecks of the system. We are planning to address these issues with increasing of the number of processor cores in our virtualization hosts and with a solid state disk upgrade of the disk array used in our virtualization environment in our next hardware upgrade cycle.


Clinica Chimica Acta | 2006

Prognostic significance of ischemia modified albumin after percutaneous coronary intervention.

Jaroslav Dušek; Josef Šťásek; Miloš Tichý; Josef Bis; Jaroslav Gregor; Jan Vojáček; Vladimir Masin; Pavel Polanský; Miroslav Brtko; Dušan Černohorský


Atherosclerosis | 2008

Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia

M. Blaha; Melanie Cermanová; V. Blaha; Petr Jarolim; Ctirad Andrys; M. Blazek; Jaroslav Maly; Lukas Smolej; Jiri Zajic; Vladimir Masin; Renata Zimova; Vit Rehacek


Transfusion and Apheresis Science | 2005

Optimization of the therapeutic procedure during LDL-apheresis—a computerized model

M. Blaha; Vladimir Masin; Pravoslav Stransky; V. Blaha; Melanie Cermanová; Jaroslav Maly; David Belada


Physica Medica | 2013

On-line integration of computer controlled diagnostic devices and medical information systems in undergraduate medical physics education for physicians

Josef Hanus; Tomas Nosek; Jiri Zahora; Ales Bezrouk; Vladimir Masin


annual conference on computers | 2007

Automated data acquisition and FEM virtual experiments in teaching medical biophysics

Jiri Zahora; Josef Hanus; Vladimir Masin; Ales Bezrouk

Collaboration


Dive into the Vladimir Masin's collaboration.

Top Co-Authors

Avatar

Josef Hanus

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Ales Bezrouk

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jiri Zahora

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

M. Blaha

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Melanie Cermanová

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

V. Blaha

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jaroslav Maly

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jiri Zajic

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

M. Blazek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Pravoslav Stransky

Charles University in Prague

View shared research outputs
Researchain Logo
Decentralizing Knowledge